-
公开(公告)号:US20130012500A1
公开(公告)日:2013-01-10
申请号:US13613495
申请日:2012-09-13
申请人: Gurdip BHALAY , Emma BUDD , Graham Charles BLOOMFIELD , Stephen Paul COLLINGWOOD , Andrew DUNSTAN , Lee EDWARDS , Peter GEDECK , Catherine HOWSHAM , Peter HUNT , Thomas Anthony HUNT , Paul OAKLEY , Nichola SMITH
发明人: Gurdip BHALAY , Emma BUDD , Graham Charles BLOOMFIELD , Stephen Paul COLLINGWOOD , Andrew DUNSTAN , Lee EDWARDS , Peter GEDECK , Catherine HOWSHAM , Peter HUNT , Thomas Anthony HUNT , Paul OAKLEY , Nichola SMITH
IPC分类号: C07D403/12 , C07D471/10 , C07D413/14 , A61K31/5377 , A61P29/00 , A61P11/00 , A61P11/08 , A61P11/06 , A61P35/00 , A61P27/02 , A61K31/497 , A61K31/551
CPC分类号: C07D519/00 , A61K31/497 , C07D403/12 , C07D471/04 , C07D471/10 , C07D471/20 , C07D473/34 , C07D487/04 , C07D487/10
摘要: A compound of Formula I in free or salt or solvate form, where R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 have the meanings as indicated in the specification, is useful for treating diseases which respond to the blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
摘要翻译: 式Ⅰ化合物,其中R1,R2,R3,R4,R5,R6,R7,R8,R9,R10和R11具有说明书中所述的含义,可用于治疗疾病, 对上皮钠通道的阻断作出反应。 还描述了含有化合物的药物组合物和用于制备化合物的方法。
-
2.TREATING DISEASES MEDIATED BY BLOCKADE OF THE EPITHELIAL SODIUM CHANNEL WITH PYRAZINE-2-CARBOXAMIDE DERIVATIVES 审中-公开
标题翻译: 用吡嗪-2-羧酰胺衍生物治疗由上皮细胞通道引起的疾病公开(公告)号:US20160068546A1
公开(公告)日:2016-03-10
申请号:US14847262
申请日:2015-09-08
申请人: Gurdip BHALAY , Emma BUDD , Graham Charles BLOOMFIELD , Stephen Paul COLLINGWOOD , Andrew DUNSTAN , Lee EDWARDS , Peter GEDECK , Catherine HOWSHAM , Peter HUNT , Thomas Anthony HUNT , Paul OAKLEY , Nichola SMITH
发明人: Gurdip BHALAY , Emma BUDD , Graham Charles BLOOMFIELD , Stephen Paul COLLINGWOOD , Andrew DUNSTAN , Lee EDWARDS , Peter GEDECK , Catherine HOWSHAM , Peter HUNT , Thomas Anthony HUNT , Paul OAKLEY , Nichola SMITH
IPC分类号: C07D519/00 , A61K31/497
CPC分类号: C07D519/00 , A61K31/497 , C07D403/12 , C07D471/04 , C07D471/10 , C07D471/20 , C07D473/34 , C07D487/04 , C07D487/10
摘要: A compound of Formula I in free or salt or solvate form, where R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 have the meanings as indicated in the specification, is useful for treating diseases which respond to the blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
摘要翻译: 式Ⅰ化合物,其中R1,R2,R3,R4,R5,R6,R7,R8,R9,R10和R11具有说明书中所述的含义,可用于治疗疾病, 对上皮钠通道的阻断作出反应。 还描述了含有化合物的药物组合物和用于制备化合物的方法。
-
公开(公告)号:US20140171412A1
公开(公告)日:2014-06-19
申请号:US14109927
申请日:2013-12-17
申请人: Mahbub AHMED , Alexander ASHALL-KELLY , Graham Charles BLOOMFIELD , Louisa GUERITZ , Jeffrey MCKENNA , Joseph MCKENNA , Simon MUTTON , Rakesh PARMAR , Jon SHEPERD , Paul WRIGHT
发明人: Mahbub AHMED , Alexander ASHALL-KELLY , Graham Charles BLOOMFIELD , Louisa GUERITZ , Jeffrey MCKENNA , Joseph MCKENNA , Simon MUTTON , Rakesh PARMAR , Jon SHEPERD , Paul WRIGHT
IPC分类号: C07D487/14 , A61K45/06 , A61K31/5383 , A61K31/553 , A61K31/519 , C07D498/14
CPC分类号: C07D487/14 , A61K31/519 , A61K31/5383 , A61K31/553 , A61K45/06 , C07D498/14
摘要: The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
摘要翻译: 本发明提供式I化合物或其药学上可接受的盐; 及其治疗用途。 本发明还提供药理活性剂和药物组合物的组合。
-
4.AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS 审中-公开
标题翻译: 氨基吡啶衍生物作为磷脂酰肌醇三激酶抑制剂公开(公告)号:US20170037032A1
公开(公告)日:2017-02-09
申请号:US15303879
申请日:2014-04-24
申请人: Benjamin Richard BELLENIE , Graham Charles BLOOMFIELD , Ian BRUCE , Andrew James CULSHAW , Edward Charles HALL , Gregory John HOLLINGWORTH , James NEEF , Matthew SPENDIFF , Simon James WATSON
发明人: Benjamin Richard BELLENIE , Graham Charles BLOOMFIELD , Ian BRUCE , Andrew James CULSHAW , Edward Charles HALL , Gregory John HOLLINGWORTH , James NEEF , Matthew SPENDIFF , Simon James WATSON
IPC分类号: C07D401/14 , C07D401/04 , A61K31/4439 , C07D417/04 , C07D413/04 , C07D417/14 , C07D491/107 , A61K31/5377 , A61K31/496 , A61K31/4545 , A61K31/55 , A61K31/444 , C07D413/14
CPC分类号: C07D401/14 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/496 , A61K31/5377 , A61K31/55 , C07D213/73 , C07D401/04 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/14 , C07D491/107
摘要: The present invention provides compounds of formula (I) which inhibit the activity of PI 3-kinase gamma isoform, which are useful for the treatment of diseases mediated by the activation of PI 3-kinase gamma isoform.
摘要翻译: 本发明提供抑制PI 3激酶γ同种型活性的式(I)化合物,其可用于治疗由PI3激酶γ同种型激活介导的疾病。
-
5.AMINO PYRAZINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS 有权
标题翻译: 氨基吡啶衍生物作为磷酸二氢吲哚-3-激酶抑制剂公开(公告)号:US20170042889A1
公开(公告)日:2017-02-16
申请号:US15303868
申请日:2014-04-24
申请人: Benjamin Richard BELLENIE , Graham Charles BLOOMFIELD , Ian BRUCE , Andrew James CULSHAW , Edward Charles HALL , Gregory John HOLLINGWORTH , James NEEF , Matthew SPENDIFF , Simon James WATSON
发明人: Benjamin Richard BELLENIE , Graham Charles BLOOMFIELD , Ian BRUCE , Andrew James CULSHAW , Edward Charles HALL , Gregory John HOLLINGWORTH , James NEEF , Matthew SPENDIFF , Simon James WATSON
IPC分类号: A61K31/497 , C07D413/14 , C07D403/04 , C07D417/04 , C07D401/04 , C07D409/14 , C07D403/14 , C07D409/04 , A61K31/5377 , C07D405/04 , C07D417/14 , C07D401/14 , C07D413/04 , C07D405/14
CPC分类号: A61K31/497 , A61K31/5377 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/14
摘要: The present invention provides compounds of formula (I) which inhibit the activity of PI 3-kinase gamma isoform, which are useful for the treatment of diseases mediated by the activation of PI 3-kinase gamma isoform.
摘要翻译: 本发明提供抑制PI 3激酶γ同种型活性的式(I)化合物,其可用于治疗由PI3激酶γ同种型激活介导的疾病。
-
-
-
-